Growth Metrics

Globus Medical (GMED) Long-Term Debt Repayments (2025)

Globus Medical posted quarterly Long-Term Debt Repayments of $450.0 million for Q1 2025.

Globus Medical (GMED) has 1 years of Long-Term Debt Repayments data on file, last reported at $450.0 million in Q1 2025.

  • For the quarter ending Q1 2025, Long-Term Debt Repayments changed N/A year-over-year to $450.0 million; the trailing twelve-month figure through Sep 2025 stood at $450.0 million (changed N/A YoY), and the FY2011 full-year result was $5.3 million, up 1445.0% from the prior year.
  • Long-Term Debt Repayments for Q1 2025 stood at $450.0 million.
  • Across five years, Long-Term Debt Repayments topped out at $450.0 million in Q1 2025 and bottomed at $450.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 449.99 Mn
Mar 31, 2025 449.99 Mn